Valuation of the economic benefits of human papillomavirus vaccine in Taiwan

Chih Hsien Liao, Jin Tan Liu, Raoh Fang Pwu, San Lin You, Ines Chow, Chao Hsiun Tang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objectives: The study aims to apply the contingent valuation method to elicit the willingness-to-pay (WTP), and measure the value of a statistic life (VSL), for human papillomavirus (HPV) vaccine in Taiwan. Methods: A total of 512 questionnaires were completed on women aged 20 to 55 years with at least one daughter, during March through May 2007. The respondents' WTP for the vaccines was elicited by double-bounded binary-choice questions under two scenarios: one was to protect themselves from cervical cancer (CC) and the other was for their daughter(s). The WTP was modeled as a function of the respondents' knowledge score, attitudes toward CC and HPV vaccine, the vaccination outcome scenarios, and individual characteristics. A log-normal survival model was constructed and the maximum-likelihood method was used for estimation. Results: The median regression-adjusted WTP was estimated at US$1098 to US$1233 (US$913-1004) for vaccinating the daughter (mother); and the VSL was estimated at approximately US$0.65 to US$4.09 (US$0.56-3. 16) million for vaccinating the daughter (mother). Conclusions: The study results provided important evidences on the monetary value women placed on a HPV vaccine, and the differential benefits between vaccinating the women and their daughters.

Original languageEnglish
JournalValue in Health
Volume12
Issue numberSUPPL. 3
DOIs
Publication statusPublished - Nov 2009

Fingerprint

Papillomavirus Vaccines
Nuclear Family
Taiwan
Economics
Uterine Cervical Neoplasms
Mothers
Vaccination
Vaccines
Survival
Surveys and Questionnaires

Keywords

  • Contingent valuation method
  • Human papillomavirus vaccine
  • Value of a statistical life
  • Willingness-to-pay

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Valuation of the economic benefits of human papillomavirus vaccine in Taiwan. / Liao, Chih Hsien; Liu, Jin Tan; Pwu, Raoh Fang; You, San Lin; Chow, Ines; Tang, Chao Hsiun.

In: Value in Health, Vol. 12, No. SUPPL. 3, 11.2009.

Research output: Contribution to journalArticle

Liao, Chih Hsien ; Liu, Jin Tan ; Pwu, Raoh Fang ; You, San Lin ; Chow, Ines ; Tang, Chao Hsiun. / Valuation of the economic benefits of human papillomavirus vaccine in Taiwan. In: Value in Health. 2009 ; Vol. 12, No. SUPPL. 3.
@article{5c26e14f62ba4f798d3c648aee1c7814,
title = "Valuation of the economic benefits of human papillomavirus vaccine in Taiwan",
abstract = "Objectives: The study aims to apply the contingent valuation method to elicit the willingness-to-pay (WTP), and measure the value of a statistic life (VSL), for human papillomavirus (HPV) vaccine in Taiwan. Methods: A total of 512 questionnaires were completed on women aged 20 to 55 years with at least one daughter, during March through May 2007. The respondents' WTP for the vaccines was elicited by double-bounded binary-choice questions under two scenarios: one was to protect themselves from cervical cancer (CC) and the other was for their daughter(s). The WTP was modeled as a function of the respondents' knowledge score, attitudes toward CC and HPV vaccine, the vaccination outcome scenarios, and individual characteristics. A log-normal survival model was constructed and the maximum-likelihood method was used for estimation. Results: The median regression-adjusted WTP was estimated at US$1098 to US$1233 (US$913-1004) for vaccinating the daughter (mother); and the VSL was estimated at approximately US$0.65 to US$4.09 (US$0.56-3. 16) million for vaccinating the daughter (mother). Conclusions: The study results provided important evidences on the monetary value women placed on a HPV vaccine, and the differential benefits between vaccinating the women and their daughters.",
keywords = "Contingent valuation method, Human papillomavirus vaccine, Value of a statistical life, Willingness-to-pay",
author = "Liao, {Chih Hsien} and Liu, {Jin Tan} and Pwu, {Raoh Fang} and You, {San Lin} and Ines Chow and Tang, {Chao Hsiun}",
year = "2009",
month = "11",
doi = "10.1111/j.1524-4733.2009.00632.x",
language = "English",
volume = "12",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier Limited",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Valuation of the economic benefits of human papillomavirus vaccine in Taiwan

AU - Liao, Chih Hsien

AU - Liu, Jin Tan

AU - Pwu, Raoh Fang

AU - You, San Lin

AU - Chow, Ines

AU - Tang, Chao Hsiun

PY - 2009/11

Y1 - 2009/11

N2 - Objectives: The study aims to apply the contingent valuation method to elicit the willingness-to-pay (WTP), and measure the value of a statistic life (VSL), for human papillomavirus (HPV) vaccine in Taiwan. Methods: A total of 512 questionnaires were completed on women aged 20 to 55 years with at least one daughter, during March through May 2007. The respondents' WTP for the vaccines was elicited by double-bounded binary-choice questions under two scenarios: one was to protect themselves from cervical cancer (CC) and the other was for their daughter(s). The WTP was modeled as a function of the respondents' knowledge score, attitudes toward CC and HPV vaccine, the vaccination outcome scenarios, and individual characteristics. A log-normal survival model was constructed and the maximum-likelihood method was used for estimation. Results: The median regression-adjusted WTP was estimated at US$1098 to US$1233 (US$913-1004) for vaccinating the daughter (mother); and the VSL was estimated at approximately US$0.65 to US$4.09 (US$0.56-3. 16) million for vaccinating the daughter (mother). Conclusions: The study results provided important evidences on the monetary value women placed on a HPV vaccine, and the differential benefits between vaccinating the women and their daughters.

AB - Objectives: The study aims to apply the contingent valuation method to elicit the willingness-to-pay (WTP), and measure the value of a statistic life (VSL), for human papillomavirus (HPV) vaccine in Taiwan. Methods: A total of 512 questionnaires were completed on women aged 20 to 55 years with at least one daughter, during March through May 2007. The respondents' WTP for the vaccines was elicited by double-bounded binary-choice questions under two scenarios: one was to protect themselves from cervical cancer (CC) and the other was for their daughter(s). The WTP was modeled as a function of the respondents' knowledge score, attitudes toward CC and HPV vaccine, the vaccination outcome scenarios, and individual characteristics. A log-normal survival model was constructed and the maximum-likelihood method was used for estimation. Results: The median regression-adjusted WTP was estimated at US$1098 to US$1233 (US$913-1004) for vaccinating the daughter (mother); and the VSL was estimated at approximately US$0.65 to US$4.09 (US$0.56-3. 16) million for vaccinating the daughter (mother). Conclusions: The study results provided important evidences on the monetary value women placed on a HPV vaccine, and the differential benefits between vaccinating the women and their daughters.

KW - Contingent valuation method

KW - Human papillomavirus vaccine

KW - Value of a statistical life

KW - Willingness-to-pay

UR - http://www.scopus.com/inward/record.url?scp=72149105315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72149105315&partnerID=8YFLogxK

U2 - 10.1111/j.1524-4733.2009.00632.x

DO - 10.1111/j.1524-4733.2009.00632.x

M3 - Article

VL - 12

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - SUPPL. 3

ER -